Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

CorMedix (CRMD) Other Operating Expenses (2016 - 2025)

CorMedix has reported Other Operating Expenses over the past 5 years, most recently at -$4.1 million for Q4 2025.

  • Quarterly results put Other Operating Expenses at -$4.1 million for Q4 2025, down 149.62% from a year ago — trailing twelve months through Dec 2025 was $4.4 million (down 84.84% YoY), and the annual figure for FY2025 was -$6.5 million, down 122.62%.
  • Other Operating Expenses reached -$4.1 million in Q4 2025 per CRMD's latest filing, down from -$2.4 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $8.3 million in Q4 2024 and bottomed at -$4.1 million in Q4 2025.
  • Median Other Operating Expenses over the past 3 years was $6.3 million (2024), compared with a mean of $4.4 million.
  • The largest annual shift saw Other Operating Expenses surged 126.87% in 2024 before it plummeted 149.62% in 2025.
  • Over 3 years, Other Operating Expenses stood at $8.2 million in 2023, then rose by 1.28% to $8.3 million in 2024, then tumbled by 149.62% to -$4.1 million in 2025.
  • Business Quant data shows Other Operating Expenses for CRMD at -$4.1 million in Q4 2025, -$2.4 million in Q3 2025, and $6.4 million in Q2 2025.